Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Clarity Pharmaceuticals (ASX:CU6) Plunges as Clinical-Stage Biotech Sell-Off Continues

Today's slide is the latest in a sustained pullback for Clarity, which has now been down approximately 26 per cent over the past one month. The broader sell-off in Australian clinical-stage biotech – Neuren Pharmaceuticals (ASX:NEU) fell 1.24 per cent today – is consistent …

Aditi Sarkar | 03 June 2026

CSL (ASX:CSL) Shares Under Pressure: Can the Healthcare Giant Rebuild Investor Confidence?

CSL Limited (ASX:CSL) remains one of Australia's most closely followed healthcare companies, but recent developments have shifted the conversation from growth expectations to execution and recovery. The biotechnology giant, known globally for its plasma therapies, influenza vaccines and specialty medicines, has entered a period …

Aditi Sarkar | 03 June 2026

Opthea (ASX:OPT) Shares Plunge 95%: What Triggered Collapse

Opthea Limited (ASX:OPT) fell sharply on its return to ASX trading on June 3, 2026, declining 97.17% to A$0.017. The extent of the fall reflects the accumulated uncertainty that built during theTrading haltperiod following the company's failed Phase 3Clinical Trialsfor wet age-related macular degeneration …

Sonal Goyal | 03 June 2026

Micro-X (ASX:MX1) Shares Rise as Human Imaging Study Begins for Head CT

Micro-X (ASX:MX1) shares edged higher on June 3, rising 2.56% to A$0.040 after the medical imaging technology company announced a significant milestone in the development of its Head CT scanner. The company revealed that the first human patient images had been acquired using its …

Aditi Sarkar | 03 June 2026

Cynata Therapeutics (ASX:CYP) Moves Higher Following Regulatory Progress in Europe

Cynata Therapeutics Ltd (ASX:CYP) shares advanced 7.27% to AUD 0.30 during the afternoon session on 3 June 2026 after the clinical-stage biotechnology company announced a favourable regulatory development for its lead cell therapy candidate, CYP-001. The gain adds to an already notable longer-term performance, …

Aditi Sarkar | 03 June 2026

What Pacific Edge's (ASX:PEB) ZOversubscribed Retail Offer Tells Us About Cxbladder's Momentum

Pacific Edge Limited (ASX:PEB), a New Zealand-headquartered cancer diagnostics company, completed its NZ$36.1M capital raising on 3 June 2026 with the allotment of shares under its retail offer. The company develops and commercialises the Cxbladder suite of non-invasive genomic urine tests, which are used …

Sonal Goyal | 03 June 2026

Why Biome (ASX:BIO) Shares Are Up Today?

Biome Australia Limited (ASX:BIO) surged 20.00% on 3 June 2026 to trade at A$0.27, as the company announced it had signed a commercial manufacturing agreement with Specialty Probiotics Australia (SPA) — a domestic GMP-licensed probiotic manufacturer. The announcement marks the execution of Phase One …

Sonal Goyal | 03 June 2026

Artrya (ASX:AYA) Shares Edge Lower Today: Volatility, Volume, and Market Context Explained

The downward movement in Artrya Limited (ASX:AYA) on 2 June 2026 highlights the volatile trading patterns frequently observed among emerging healthcare equipment and services listings on the Australian Securities Exchange. Closing the session at A$4.680, the share price fluctuated visibly throughout the day. Despite …

Aditi Sarkar | 02 June 2026

Austco Healthcare (ASX:AHC) Falls Sharply as Investors Weigh Growth and Sector Sentiment

Austco Healthcare Ltd (ASX:AHC) was among the weaker performers on the Australian market on 2 June 2026, with shares falling 9.62% to A$0.235. The decline drew attention from investors as the healthcare technology company experienced substantially higher trading activity than usual.

Aditi Sarkar | 02 June 2026

Why PolyNovo Shares (ASX:PNV) Slumped 5% Today on the ASX

Shares in PolyNovo Ltd (ASX:PNV) were among the biggest losers on the Australian share market on 2 June 2026, with the stock falling 5.15% to AUD 1.10 based on available market data. The move placed PolyNovo on the list of the day's worst-performing ASX …

Aditi Sarkar | 02 June 2026
Support

Hi! How can we help you today?

Loading…